Hypogonadotropic hypogonadism in a patient with morbid obesity

Obesity Surgery

Volumn 17, Issue 8, 2007, Pages 1127-1131

  Mollar Puchades, Miguel Angel ^a   Gómez, Rosa Cámara ^a   Del Olmo García, Maria Isabel ^a   Ponce Marco, José Luis ^a   Portolés, Raquel Segovia ^a   Galiana, Pablo Abellán ^a   Sellés, Francisco Piñón ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bariatric surgery; Hyperestrogenism; Hyperprolactinemia; Hypogonadotropic hypogonadism; Morbid obesity; Pituitary adenoma; Weight loss

Indexed keywords

CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; TESTOSTERONE;

ABDOMINAL SURGERY; ADULT; ARTICLE; BARIATRIC SURGERY; CANCER INHIBITION; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG MECHANISM; ENDOCRINE DISEASE; HUMAN; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS TUMOR; MALE; MORBID OBESITY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADENOMA; ADULT; COMORBIDITY; GASTROPLASTY; HUMANS; HYPERPROLACTINEMIA; HYPOGONADISM; LUTEINIZING HORMONE; MAGNETIC RESONANCE IMAGING; MALE; OBESITY, MORBID; PITUITARY FUNCTION TESTS; PITUITARY NEOPLASMS;

EID: 35748956448     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9190-3     Document Type: Article

References (20)

1. Yashkov YI, Vinnitsky LI, Poroykova MV et al. Some hormonal changes before and after vertical banded gastroplasty for severe obesity. Obes Surg 2000; 10: 48-53.
2. Ram E, Vishne T, Diker D et al. Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels. Obes Surg 2005; 15: 1118-23.
3. Papavramidis ST, Zisiadis AC, Karamouzis MN et al. Alterations in thyroid hormones and thyrotropin (TSH) in morbidly obese patients before and after vertical gastroplasty. Obes Surg 1995; 5: 298-301.
4. Ramos AP, de Abreu MR, Vendramini RC et al. Decrease in circulating glucose, insulin and leptin levels and improvement in insulin resistance at 1 and 3 months after gastric bypass. Obes Surg 2006; 16: 1359-64.
5. Kopp HP, Krzyzanowska K, Schernthaner GH et al. Relationship of androgens to insulin resistance and chronic inflammation in morbidly obese premenopausal women: studies before and after vertical banded gastroplasty. Obes Surg 2006; 16: 1214-20.
6. Schuetz P, Peterli R, Ludwig C et al. Fatigue, weakness, and sexual dysfunction after bariatic surgery - not an unusual case but an unusual cause. Obes Surg 2004; 14: 1025-28.
7. Roland J. Endocrinological aspects of obesity. Clin Endocrinol Metab 1984; 13: 597-612.
8. Derby CA, Zilber S, Brambilla D et al. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol 2006; 65: 125-31.
9. Jane JA Jr, Laws ER Jr. The management of non-functioning pituitary adenomas. Neurol India. 2003; 51: 461-65.
10. Chanson P, Salenave S. Diagnosis and treatment of pituitary adenomas. Minerva Endocrinol 2004; 29: 241-75.
11. Gapstur SM, Kopp P, Gann PH et al. Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: the CARDIA Male Hormone Study. Int J Obes 2007; 31: 685-91.
12. Lima N, Cavaliere H, Knobel M et al. Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat. Int J Obes 2000; 24: 1433-7.
13. de Boer H, Verschoor L, Ruinemans-Koerts J et al. Letrozole normalizes serum testosterone in severely obese men with hypogonadic hypogonadism. Diabetes Obes Metab 2005; 7: 211-5.
14. Gillam MP, Middler S, Freed DJ et al. The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 2002; 87: 4447-51.
15. Giagulli VA, Kaufman JM, Vermeulen A. Pathogenesis of decreased androgen levels in obese men. J Clin Endocrinol Metab 1994; 79: 997-1000.
16. Mortimer CH, Besser GM, McNeilly AS et al. Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J 1973; 4: 73-7.
17. Isidori AM, Caprio M, Strollo F et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999; 84: 3673-80.
18. Neve HJ, Bhatti WA, Soulsby C. Reversal of hair loss following vertical gastroplasty when treated with zinc sulphate. Obes Surg 1996; 6: 63-5.
19. Kinzl JF, Trefalt E, Fiala M et al. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg 2001; 11: 455-8.
20. Zumoff B, Miller LK, Strain GW. Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism 2003; 52: 1126-8.